The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease-Reference-Cited by-同舟云学术

The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease

Published:2005-12 Issue:8 Volume:11 Page:521-522
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Lu Chin-Song,Simons Erik J.,Wu-Chou Yah-Huei,Fonzo Alessio Di,Chang Hsiu-Chen,Chen Rou-Shayn,Weng Yi-Hsin,Rohé Christan F.,Breedveld Guido J.,Hattori Nobutaka,Gasser Thomas,Oostra Ben A.,Bonifati Vincenzo

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference10 articles.

1. Cloning of the gene containing mutations that cause PARK8-linked parkinson's disease;Paisan-Ruiz;Neuron,2004

2. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology;Zimprich;Neuron,2004

3. A frequent LRRK2 gene mutation associated with autosomal dominant parkinson's disease;Di Fonzo;Lancet,2005

4. A common LRRK2 mutation in idiopathic Parkinson's disease;Gilks;Lancet,2005

5. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations;Kachergus;Am J Hum Genet,2005

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Worldwide Distribution of LRRK2 Mutations in Parkinson’s Disease;Neurodegenerative Disease Management;2023-12

2. Astrocytes Differentiated from LRRK2-I1371V Parkinson’s-Disease-Induced Pluripotent Stem Cells Exhibit Similar Yield but Cell-Intrinsic Dysfunction in Glutamate Uptake and Metabolism, ATP Generation, and Nrf2-Mediated Glutathione Machinery;Cells;2023-06-08

3. LRRK2: Genetic mechanisms vs genetic subtypes;Handbook of Clinical Neurology;2023

4. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease;Genes;2022-10-25

5. Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson’s disease;Frontiers in Neuroscience;2022-09-20